Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
424.00    -15.00 (-3.42%)
Bid:
426.00
Ask:
430.00
Spread: 4.00 (0.939%)
Market Cap: £208.53m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Interim Management Statement

26 Oct 2012 07:00

RNS Number : 5898P
Zotefoams PLC
26 October 2012
 



26 October 2012

 

Zotefoams plc

("Zotefoams" or "the Company")

 

Interim Management Statement for the Quarter ended 30 September 2012

 

26 October 2012 - Zotefoams, which manufactures and sells high-performance foams, today announces its interim management statement for the third quarter ended 30 September 2012.

 

Third quarter Polyolefin foam sales increased by approximately 3% in constant currency compared to the same period last year. Sales growth in North America and Rest of World was around 6% while we experienced more modest growth in UK and Continental Europe. The impact of a weaker euro reduced the sterling value of European sales by approximately 10% while there was a small positive impact on sales elsewhere from relative US dollar strength compared with the third quarter in 2011.

 

In the third quarter of 2011 there was high demand for our T-Tubes® insulation products and, due to timing of projects, comparative sales were much lower in 2012. As a result, revenue from our High-Performance Polymers ("HPP") segment was approximately 20% below the same period last year despite an increase in sales of our patented ZOTEK® F fluoropolymer foams. While sales in HPP have historically been subject to short term fluctuations, we remain confident of strong underlying growth in this segment, much of which is to the aviation market.

 

In July and August 2012 MuCell Extrusion LLC ("MEL"), which licenses foaming technology, made important advances within the film and sheet markets. Agreements with Dow Chemical and Styron to license-in their complementary patents have enhanced our ability to offer attractive licences in packaging technology, and activity and interest levels have increased as a direct result. The development pipeline of new projects continues to grow from a small base and in the medium term we expect good progress in conversion of additional signed MEL licences. Currently MEL is a developmental business which is cash generative and we are increasing investment commensurate with our expectations for growth over the coming years.

 

For the third quarter the euro-denominated price of low density polyethylene (LDPE), our main raw material, was at a similar average price compared to the same period last year.

 

The Company continues to progress, with a forward order book into early 2013. Although we are mindful of the uncertain economic environment and the potential for movements in exchange rates to have a translation impact on our reported results, the Board remains confident of a satisfactory outcome for the year and continued progress in the future.

 

 

Enquiries:

Zotefoams plc

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director

FTI Consulting

0207-831-3113

Ben Brewerton, John Dineen, Victoria Foster Mitchell

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUVSBRUSARUAA
Date   Source Headline
15th Apr 20257:00 amRNSIssue of Equity
11th Apr 20254:14 pmRNSNotification Of Transactions Of Directors/PDMRs
9th Apr 20253:25 pmRNSHolding(s) in Company
2nd Apr 20254:37 pmRNSDirector Declaration
20th Mar 20253:16 pmRNSHolding(s) in Company
19th Mar 20251:52 pmRNSHolding(s) in Company
18th Mar 20257:00 amRNSPreliminary Results
17th Mar 20251:00 pmRNSResults Presentation on Investor Meet Company
12th Mar 20252:50 pmRNSNotification Of Transactions Of Directors/PDMRs
10th Mar 20257:00 amRNSStrategic Investment in Asia
4th Mar 20254:41 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNSCFO Retirement
27th Feb 20253:58 pmRNSHolding(s) in Company
12th Feb 20251:35 pmRNSNotification Of Transactions Of Directors/PDMRs
27th Jan 202511:34 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSTrading Update & Notice of Capital Markets Day
15th Jan 202511:04 amRNSNotification Of Transactions Of Directors/PDMRs
24th Dec 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
18th Dec 20247:00 amRNSUpdate on ReZorce
13th Dec 20243:41 pmRNSHolding(s) in Company
12th Dec 20249:47 amRNSNotification Of Transactions Of Directors/PDMRs
26th Nov 20244:21 pmRNSHolding(s) in Company
25th Nov 20245:51 pmRNSHolding(s) in Company
12th Nov 20242:27 pmRNSNotification Of Transactions Of Directors/PDMRs
4th Nov 20247:00 amRNSTrading Update
14th Oct 202410:02 amRNSNotification Of Transactions Of Directors/PDMRs
8th Oct 20242:17 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Sep 20241:20 pmRNSNotification Of Transactions Of Directors/PDMRs
23rd Aug 202411:42 amRNSHolding(s) in Company
14th Aug 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
6th Aug 20247:00 amRNSInterim Results
12th Jul 20244:14 pmRNSNotification Of Transactions Of Directors/PDMRs
8th Jul 20247:00 amRNSNotice of Results and Investor Presentation
5th Jul 20241:14 pmRNSHolding(s) in Company
13th Jun 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
5th Jun 20243:08 pmRNSNotification Of Transactions Of Directors/PDMRs
31st May 20244:45 pmRNSHolding(s) in Company
30th May 20243:07 pmRNSDirector/PDMR Shareholding
28th May 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
22nd May 20242:01 pmRNSResult of the 2024 Annual General Meeting
22nd May 20247:00 amRNSTrading Update and Group CEO Succession
15th May 202410:07 amRNSNotification Of Transactions Of Directors/PDMRs
15th May 20247:00 amRNSUpdate on ReZorce® & beverage carton Media Launch
10th May 20247:01 amRNSNotification Of Transactions Of Directors/PDMRs
10th May 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
7th May 20247:00 amRNSZotefoams and Shincell Global Alliance
19th Apr 20247:00 amRNSExclusivity agreement with Design Blue Limited
19th Apr 20247:00 amRNS2023 Annual Report & Notice of 2024 AGM
12th Apr 20244:34 pmRNSNotification Of Transactions Of Directors/PDMRs
28th Mar 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.